Introduction
Inorganic arsenic, a commonly occurring pollutant of drinking water, is a potent toxicant and carcinogen, causing cancer in the lung, skin, and bladder, and possibly also in the liver, kidney, and prostate. [1] [2] [3] Arsenic is clastogenic, 4 but only a weak inducer of point mutations. [5] [6] [7] Thus, other mechanisms are probably involved in the carcinogenic effects of arsenic.
Recently, it has been suggested that arsenic acts as a carcinogen by modifying epigenetic mechanisms. [8] [9] Indeed, hypermethylation of the tumor suppressor genes p53 and p16 was observed in arsenic-induced skin tumors. [10] [11] In urothelial tumors from patients living in an endemic arsenic-exposed area in Taiwan, low expression of the p16 protein was
shown to be much more common (81%) than in tumors from patients in a non-exposed area (25%), indicating that p16 is important in arsenic-related carcinogenesis. 12 Expression of hMSH2, a key gene involved in the DNA mismatch repair system, has been found to be down-regulated with increasing severity of arsenic-related skin symptoms, 13 but whether or not this is mediated through modification of DNA methylation of the mismatch repair genes is not known. MLH1 is an important component in the mismatch repair system and promoter methylation of the MLH1 gene has been implicated in the development of gastric and colorectal carcinoma. [14] [15] The Long Interspersed Nuclear Element 1 (LINE1) retrotransposable elements make up about 17% of human DNA 16 and methylation status of LINE1 is often used as a proxy to represent global DNA methylation. 17 Treatment with arsenic results in global DNA hypomethylation in cell cultures 18 and in mice. 19 The CpG sites in LINE1 are usually heavily methylated, and genome-wide loss of methylation from these sites has been regarded as a common epigenetic event in malignancy. 20 Susceptibility to arsenic toxicity varies widely between individuals and populations.
The efficiency of arsenic metabolism, measured as the formation and urinary excretion of arsenic metabolites, may be one important susceptibility factor. Inorganic arsenic is metabolized in the body by a series of reduction and methylation reactions that produce methylarsonic acid (MMA) and dimethylarsinic acid (DMA), both of which are excreted in the urine. 21 Trivalent MMA is considered to be the most toxic metabolite 22 and a higher fraction of MMA in urine is associated with more toxic effects. [23] [24] In line with that, a higher fraction of MMA or a lower fraction of DMA in urine is associated with a lower rate of arsenic excretion in urine. 21, 25 The main methyltransferase in arsenic metabolism is arsenic (+3 oxidation state) methyltransferase (AS3MT) 26 , which can methylate both inorganic arsenic and MMA. We have previously shown that AS3MT genotype determines the fractions of the different arsenic metabolites in urine. 27 The aim of this study was to evaluate epigenetic effects of arsenic exposure in cancerrelated genes and repetitive DNA sequences in individuals who have been exposed through drinking water, and to determine the possible influence of arsenic metabolism. We chose to measure epigenetic changes in the p16 and MLH1 genes, as p16 and mismatch repair genes have previously been associated with arsenic-related malignancy, and both are important for tumor suppression by regulating cell proliferation and maintain genome stability. We hypothesized that if there is an epigenetic effect of arsenic on these genes, they may be altered in blood cells as well. LINE1 was measured as a proxy for global DNA methylation.
Methods and materials

Subjects
We studied 202 women living on the Andean plateau (3,800 m above sea level) in Northern Argentina, an area that has minimal industrial and vehicle-derived pollution. However, in some villages there are elevated concentrations of arsenic in drinking water. 28 Most of the study participants (N = 161) were from the village San Antonio de los Cobres, which has about 5,000 inhabitants, and 200 µg/L arsenic in the drinking water. The remaining participants (N = 41) were from small surrounding villages with lower concentrations of arsenic in the water.
The study individuals were recruited with the assistance of the medical personnel, except in a small mining village, Tolar Grande, where we went from house to house to explain the project and invite the adults to participate. We included only women, as men were often away from home for longer periods for work, and therefore had another pattern of exposure to toxic elements in food and drinking water. We invited all women who were interested to participate in our study. Only four of the study participants smoked cigarettes and one reported drinking alcohol, but almost half of the women (46.5%) often chewed coca leaves. As reported previously, interviews with the study participants revealed that almost all women drank public drinking water exclusively, and that their diets consisted mainly of corn, beans, chicken, and pork. 29 Only 3 women reported taking any medication at the time of the study; one was being treated for gastritis and two for hypertension. The questionnaire data showed that the women were homogenous with regard to factors that may influence the peripheral blood methylation, i.e., most of the women did not use any medication, smoke tobacco or drink alcohol. Further, their diet was very similar. The women were asked if they had had any history of or current diseases and their hands were inspected for arsenic-related skin lesions.
Informed consent, both oral and written, was provided by all the study participants. The study was approved by the Ministry of Health in Salta, Argentina, and the Regional Ethical
Committee of Karolinska Institutet, Sweden.
Blood and urine collection
All the biological samples were collected during daytime as non-fasting spot samples at the local health clinics and at the hospital in San Antonio de los Cobres. Peripheral blood for DNA extraction (N = 202) was collected in K 2 EDTA tubes (Vacuette ; Greiner, Germany), blood for element analysis (N = 202) was collected in lithium heparin tubes (Vacuette ), and blood for RNA extraction (N = 122; the first women studied) was collected in PAX tubes (Beckton Dickinson, Franklin Lakes, NJ). Spot urine samples were collected and processed as described previously. 30 Blood and urine samples were kept at -20°C before and after transport (with cooling blocks) to Sweden for analysis.
Analysis of arsenic and other elements in urine
The concentration of arsenic metabolites, i.e. MMA, DMA, and remaining unmethylated inorganic arsenic in urine were measured using high performance liquid chromatography (HPLC) coupled with hydride generation and inductively coupled plasma mass spectrometry (ICPMS) (Agilent 7500ce; Agilent Technologies, Japan) employing appropriate quality control. 31 The sum of metabolite concentrations was used to assess arsenic exposure. The fractions of the different metabolites in urine were used to assess the efficiency of arsenic metabolism. We also measured cadmium in urine and selenium and zinc in blood. Cadmium has been reported to influence DNA methylation. [32] [33] [34] Selenium and zinc represent nutritional status. Cadmium in urine and selenium and zinc in blood were analyzed using ICPMS (Agilent 7500ce) with a collision/reaction cell system (Agilent 7500ce) with analytical accuracy ascertained from commercially available reference materials as described previously. [35] [36] Concentrations of elements in urine were adjusted to the mean specific gravity of urine (1.020 g/mL) measured with a digital refractometer (EUROMEX RD 712 clinical refractometer; EUROMEX, Arnhem, the Netherlands).
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DNA isolation and pyrosequencing
DNA was isolated using the QIAGEN DNA Blood Midi kit (Qiagen, Hilden, Germany). One µg of DNA (50 ng/µL) was bisulfite-treated using an EpiTect ® kit (Qiagen). Bisulfite-treated DNA (0.6-1 µl) was used in a 15-to 25-µL PCR reaction using the Pyromark PCR kit (Qiagen). One of the PCR primers was biotinylated. The PCR product was purified using Streptavidin Sepharose High Performance beads (Amersham Biosciences, Uppsala, Sweden).
The Sepharose beads containing immobilized PCR products were purified, washed, and denatured using 0.2 N NaOH, and washed again using a vacuum prep tool (Pyrosequencing Inc., Westborough, MA). Twelve µL of pyrosequencing primer (0.3 µmol/L) was annealed to the purified single-stranded PCR product and pyrosequencing was done using the PSQ HS96
Pyrosequencing System (Qiagen). The degree of methylation was expressed as percentage of methylated cytosines divided by the sum of methylated and unmethylated cytosines. Bisulfite conversion was verified using non-CpG cytosine residues as built-in controls, and at least >95% conversion of cytosine at a non-CpG site in the pyrosequencing amplicon ensured successful bisulfite conversion.
Commercially available kits (Qiagen) were used to measure the methylation of p16 at 7
CpG sites (between +148 and +174 in exon 1; GenBank accession no. L27211, http://www.ncbi.nlm.nih.gov/genbank/GenbankSearch.html) specific for the p16 transcript, for MLH1. We also analyzed negative controls (whole genome amplified DNA and unmethylated DNA from Qiagen). The average methylation for these samples ranged between 1-2%.
Genotyping and gene expression analysis
We have previously shown that AS3MT haplotype 1, constituted by considering the polymorphisms of rs7085104, rs3740400, rs3740393, rs3740390, rs11191439, rs11191453, rs10748835, and rs1046778 (haplotype frequency 16.5% in this study population), is associated with more inorganic arsenic, more MMA and less DMA in urine (relative amounts), i.e. a slower metabolism of arsenic. 27 The most common haplotype in this population (haplotype 2) is associated with a more efficient metabolism. We therefore focused on hapotype 1 in this study. All polymorphisms, but one (rs11191439), are intronic.
Some of the intronic polymorphisms are functional, as they are associated with altered expression of the AS3MT gene. 39 Genotyping for polymorphisms in the AS3MT was performed in peripheral blood DNA using Sequenom TM technology (Sequenom Inc.,San Diego, CA) at the Swegene DNA facility at Malmö University Hospital, Malmö, Sweden, as described previously. 27 Blood was collected in PAX tubes and stored at -80°C until the RNA was extracted using the PAXgene Blood RNA kit (PreAnalytiX, Hombrechtikon, Switzerland). RNA concentration and purity were evaluated on a NanoDrop spectrophotometer (NanoDrop Products,Wilmington, DE) and integrity (RNA integrity number, RIN) was evaluated on a Bioanalyzer 2100 (Agilent, Santa Clara, CA), and the results showed good RNA quality for the large majority of the samples (RIN>7.5). Of 122 available PAX tubes for RNA extraction, 90 samples with a sufficient amount of good quality RNA were selected for gene expression analysis (characteristics of the individuals in Table 1 
Statistical analysis
We used Spearman's rank (r s ) correlation analysis to assess bivariate correlations between epigenetic markers (individual C-positions in p16 and MLH1 and also averages of all CpG sites measured for p16, MLH1, and LINE1), arsenic concentration and the fractions of arsenic metabolites in urine, p16 and MLH1 gene expression, and the characteristics of the women.
Checking of the linearity of associations with outcome variables by P-P plots and visual inspection of scatter plots indicated that there were linear relationships between arsenic exposure on one hand and DNA methylation and gene expression on the other. In the further analyses we selected the CpG showing the strongest correlation and the best fit with linearity to arsenic exposure, in order to avoid too many comparisons. The linear fit improved with log 2 -transformed urinary arsenic concentration (Supplementary Figures 1and 2) and, therefore, log 2 -transformed values were used in the linear regression analysis to estimate the associations ( -coefficients) of urinary arsenic concentrations with epigenetic markers. There was a strong correlation between individual concentrations of arsenic metabolites and total urinary arsenic (r s = 0.81-0.99) and therefore only total urinary arsenic was used in relation to DNA methylation. We performed adjusted regression analysis, controlling for age and coca use, since these factors were weakly associated with the outcomes (univariate linear regression analysis, p<0.2). In addition, we controlled for concentrations of cadmium in urine, which we has previously found to be associated with epigenetic modifications in vitro 33 and selenium and zinc in blood, which are important for anti-oxidative defense. Cadmium concentration in urine was log 2 -transformed to obtain normal distributions of the residuals.
We did not adjust for BMI, as it was highly correlated with age (r s = 0.46). The same analysis was performed for p16 and MLH1 gene expression as was performed for p16 and MLH1 methylation.
To evaluate the effect of efficiency of arsenic metabolism on epigenetic markers, we analyzed the associations between the fractions (percentages; as continuous variables) of the different arsenic metabolites and epigenetic markers, taking total arsenic concentration in urine into account, since the efficiency of metabolism is affected by the level of exposure. 21 We also evaluated the effect of the major arsenic metabolizing gene AS3MT on the association between arsenic and p16 and MLH1 methylation (in individuals who were not first-degree relatives, N = 172). First, we analyzed the p16 and MLH1 methylation by genotype (the degree of methylation for groups with 0, 1, or 2 copies). Then, we evaluated the effect of arsenic on gene methylation, stratifying for haplotype copy number. Third, AS3MT haplotype was entered as a categorical variable in the analysis. In order to obtain an effect estimate in carriers with different numbers of haplotype copies, we performed regression analysis of urinary arsenic and p16 and MLH1 methylation, stratified by AS3MT
haplotype. All these analyses were adjusted for age and coca chewing.
Any P value < 0.05 was considered statistically significant. All statistical analyses were performed using SPSS (version 18; SPSS, Chicago, IL).
Results
Descriptive data for the study participants, the concentrations of elements in blood and urine, and the fractions of urinary metabolites are shown in Table 1 Table 1 ).
The arsenic concentrations in urine were positively correlated with the degree of average p16 and MLH1 methylation (r s -values of 0.21 and 0.20, respectively; Table 2 ), but not with LINE1 methylation. Position 1 in both p16 and MLH1 (the first CpG site in each amplicon) was used in the subsequent analyses as this showed the strongest linearity, although rather weak, with arsenic concentrations in urine (Supplemental Figures 1 and 2) , compared with the average degree of methylation (Table 2) In the linear regression analysis, urinary arsenic concentrations were found to be positively associated with p16 methylation (position 1: β = 0.14; P = 0.0028) ( Table 3) .
Adjustments for age and coca use, and also urinary cadmium, selenium and zinc concentrations in blood, did not alter the association (β = 0.14; P = 0.0039). The fractions of inorganic arsenic and DMA in urine, but not MMA, were associated with p16 methylation (position 1) ( Table 3 ). The percentage of inorganic arsenic showed the strongest association (β 1 = 0.026; P = 0.010), and the association of the total concentrations of arsenic in urine remained essentially the same (β 2 = 0.12; P = 0.013). Also in the model with percentage of DMA as main predictor (β 1 = -0.017; P = 0.043), the association of the total concentrations of arsenic remained the same (β 2 = 0.12; P = 0.013) ( Table 3) . Further adjustments for age and coca use decreased the association of inorganic arsenic with p16 methylation by about 10%; the association with DMA became statistically non-significant (P = 0.082).
Arsenic concentrations were also found to be positively associated with MLH1 methylation (position 1: β = 0.28, P = 0.0011), and the effect estimate became even stronger after adjustments (Table 3) . However, the metabolite fractions were not associated with MLH1 methylation (Table 3 ). The average degree of both p16 and MLH1 methylation showed similar, but somewhat weaker, associations with urinary arsenic and arsenic fractions (data not shown). The linear regression analysis showed no association between arsenic concentrations in urine, or arsenic metabolite fractions, and LINE1 methylation (Supplemental Table 2 ).
Evaluation of the influence of the major arsenic metabolizing gene AS3MT showed that the slow arsenic-metabolizing AS3MT haplotype 1 had an effect on p16 methylation (Table   4 ). Individuals carrying two or one copies of the AS3MT haplotype 1 showed more methylation of p16 than null carriers of the haplotype (P = 0.022 for the main effect of the haplotype; adjusted P = 0.043) ( Table 4) . A haplotype dosage effect was observed with on average, 13% more p16 methylation per haplotype copy. No effect of the AS3MT haplotype 1 was observed for MLH1 methylation (P = 0.86 for the main effect of the haplotype; adjusted P = 0.82).
As shown in Table 1 , the descriptive data for the 90 women who had their blood samples used for gene expression were similar to those for the whole cohort of 202 women.
There was a negative association between expression of p16 (N = 90) and log 2 -transformed arsenic in urine (β = -1.45; P = 0.0094 and β = -1.48; P = 0.0091 when adjusted for age and coca use) (Figure 2 ). There was one influential outlier with very high p16 expression. After removal of this individual, the association became much weaker (β = -0.81; P = 0.081). The outlier did not show any characteristics that deviated from the rest of the population. Urinary arsenic concentrations were not associated with the degree of MLH1 expression (β = -0.0082; P = 1.00). There was no correlation between p16 or MLH1 methylation and p16 or MLH1 expression
Discussion
In this study we found that women who had long-term exposure to arsenic through drinking water demonstrated a correlation with increased DNA methylation of both the tumor suppressor gene p16 and the DNA mismatch repair gene MLH1. We did not find any association between methylation and gene expression in a subset of samples. However, arsenic exposure was found to be associated with reduced expression of p16 mRNA in peripheral blood, but this result needs to be interpreted cautiously, as it was partly influenced by an outlier. The efficiency of arsenic metabolism showed relationship with the degree of p16 gene methylation. Women with a higher fraction of the dimethylated arsenic metabolite (DMA) in urine, which is associated with faster arsenic excretion and less toxicity, 21 had a lower degree of p16 methylation. Surprisingly, only the fraction of inorganic arsenic in urine,
and not that of MMA, showed a positive association with p16 methylation. This indicates that a high percentage of MMA in urine, which is generally associated with more toxic effects, including genotoxicity, 23, 40 may be less relevant to epigenetic changes. Further support for the role of arsenic metabolism in susceptibility to arsenic-related epigenetic effects came from the observed association of genotype of the major arsenic-metabolizing gene AS3MT:
i.e., the effect of arsenic on p16 methylation increased with increasing number of copies of the slow metabolism haplotype.
We conducted this study on a homogeneous population in which subjects differed very little in terms of diet, as revealed from questionnaire response, and exposure to industrial pollution. Also, there were very few smokers and only one subject reported alcohol consumption. A weakness of the study was the analysis of DNA methylation in the DNA isolated from whole blood only, and not from different populations of blood cells. Despite the fact that methylation in whole blood cells has been used successfully for the study of epigenetic changes in relation to disease, 41 the effects of exposure to toxicants on DNA methylation may be different in different types of blood cells. 42 The women did not report any malignancy and it was thus not possible to analyze epigenetic changes in arsenic-related tumors.
The p16 is a key regulator of the cell cycle and hypermethylation of p16 is found in tumors of the colon, liver, and skin, 43 as well as in premalignant lesions. [44] [45] [46] Previous studies on p16 alterations in relation to arsenic exposure were smaller and had no information about individual arsenic exposure and/or influence of arsenic metabolism. Fifty-one subjects exposed to arsenic through drinking water in India showed hypermethylation of p16 at high levels of arsenic in water (>250 ug/L). 11 Studies of individuals exposed to arsenic-rich coal in unventilated homes in China indicated trends of increasing p16 methylation in peripheral blood lymphocytes (N = 103) 13 , and reduced amounts of p16 protein in skin samples (N = 51) 47 , with increasing severity of arsenic-related skin changes (hyperpigmentation, hypopigmentation, or squamous adenocarcinoma). However, the comparison between our study and the two reports by Zhang et al. 13, 47 is not straightforward, as the arsenic-rich coal probably contained several other carcinogenic compounds that could induce alterations in
p16.
MLH1 is an important component in the maintenance of genomic stability, both for repair of small DNA mismatches and for proper recombination during meiosis. 48 Promoter methylation of the MLH1 gene has been implicated in the development of gastric and colorectal carcinoma. [14] [15] Increasing DNA damage with increasing arsenic exposure and impaired expression of genes involved in different DNA repair systems, including the mismatch repair gene hMSH2, have been reported in humans. Again, the arsenic exposure came from arsenic-rich coal, and compounds other than arsenic may have had a negative effect on the repair systems. 13 We could not show reduced MLH1 expression in relation to arsenic exposure, and arsenic metabolism did not significantly influence MLH1 methylation.
The association of arsenic exposure and MLH1 methylation we observed should be treated with caution as there was a high degree of correlation between p16 and MLH1 methylation.
Arsenic is metabolized mainly by AS3MT, and different polymorphisms in this gene influence the efficiency of the arsenic metabolism. 27 The population under study has a very efficient arsenic metabolism compared to other populations. 28 This is probably largely determined by the low frequency (16.5%) of the AS3MT slowly metabolizing haplotype 1 and a very high frequency (70%) of the quickly metabolizing haplotype 2 in this population compared to most other populations. 27, 49 The efficient arsenic metabolism may explain that the average level of p16 methylation in peripheral blood was low (on average 3%) in spite of the fairly high arsenic exposure. The low level of p16 methylation detected here are consistent with unmethylated CpG islands, since a low level of DNA methylation (~3%) is typically found in the promoter-region CpG islands 50 and similar to p16 methylation in blood samples from non-exposed Chinese individuals (2%). In contrast, Chinese patients with arsenic-related diseases demonstrated much higher p16 methylation levels in blood (42%). 47 It should be mentioned that one reason behind the discrepancies in the previous studies may be due to differences in AS3MT genotype distribution which was not reported before.
However, despite the low p16 methylation levels we could still show a significant effect of arsenic on methylation of p16 and MLH1. Still, since the levels of methylation were low in this population, this warrants some caution and future studies are needed to follow up our findings.
Despite the fact that there was a wide range of arsenic exposure, we found no indications that arsenic affected global DNA methylation. This contrasts with the results of a study in Bangladesh where arsenic exposure through drinking water was found to be positively associated with increased global DNA methylation. 51 This difference in findings may be attributed to the differences in AS3MT genotypes and in the methods used to measure global DNA methylation. The investigators used [ 3 H]-methyl incorporation assay assessing methylation at all genomic CpG sites and we used bisulfite-PCR pyrosequencing to quantitate LINE1 methylation, which served as a surrogate for global DNA methylation.
In conclusion, we have shown that arsenic levels in individuals with prolonged arsenic exposure were correlated with increased DNA methylation in tumor suppressor genes in peripheral blood. Importantly, changes seen with inorganic arsenic suggest it may be more toxic for the epigenome than the monomethylated MMA metabolite.
Supplementary material
Supplementary Tables 1 and 2 Adjusted for specific gravity of urine (1.020 g/ml). methylation (%) = α1 + β 1 arsenic concentration (log 2 -tranformed).
b P for β 1 from the model: p16 and MLH1 methylation (%) = α 1 + β 1 AS3MT haplotype 1 + β 2 arsenic concentration (log 2 -transformed).
c P for β 1 from the model above adjusted for age and coca chewing. 
